Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
BlackRock
New York
| $5.32B | +$119M | 81 | 0.09% | Increased |
|
| 2 |
Vanguard Group
Malvern,
Pennsylvania
| $4.73B | +$45M | 79 | 0.07% | Increased |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $3.71B | +$238M | 61 | 0.19% | Increased |
|
| 4 |
State Street
Boston,
Massachusetts
| $2.31B | +$119M | 71 | 0.08% | Increased |
|
| 5 |
Morgan Stanley
New York
| $1.82B | +$67.7M | 87 | 0.11% | Increased |
|
| 6 |
Dimensional Fund Advisors
Austin,
Texas
| $1.66B | -$14.1M | 32 | 0.36% | Reduced |
|
| 7 |
Dodge & Cox
San Francisco,
California
| $1.36B | -$7.62M | 1 | 0.73% | Reduced |
|
| 8 |
SVGI
Sozo Ventures GP II
Redwood City,
California
| $1.33B | $0 | 1 | 100% | Maintained |
|
| 9 |
Primecap Management
Pasadena,
California
| $1.28B | -$131M | 5 | 0.98% | Reduced |
|
| 10 |
Geode Capital Management
Boston,
Massachusetts
| $1.27B | +$20M | 85 | 0.08% | Increased |
|
| 11 |
Bank of America
Charlotte,
North Carolina
| $1.22B | +$37.1M | 90 | 0.08% | Increased |
|
| 12 |
Janus Henderson Group
London,
| $1.21B | +$4.29M | 19 | 0.55% | Increased |
|
| 13 |
GS
Gilead Sciences
Foster City,
California
| $1.16B | -$1.31M | 3 | 64.49% | Reduced |
|
| 14 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $1.15B | +$378M | 10 | 0.71% | Increased |
|
| 15 |
Wellington Management Group
Boston,
Massachusetts
| $1.15B | -$295M | 21 | 0.2% | Reduced |
|
| 16 |
RTW Investments
New York
| $1.07B | +$37.7M | 7 | 13.16% | Increased |
|
| 17 |
Goldman Sachs
New York
| $1.02B | +$6.8M | 58 | 0.13% | Increased |
|
| 18 |
Fisher Asset Management
Camas,
Washington
| $939M | +$13.8M | 3 | 0.34% | Increased |
|
| 19 |
Franklin Resources
San Mateo,
California
| $887M | -$29.7M | 23 | 0.22% | Reduced |
|
| 20 |
ARK Investment Management
St. Petersburg,
Florida
| $870M | -$23.4M | 3 | 5.18% | Reduced |
|
| 21 |
UBS Group
Zurich,
Switzerland
| $844M | -$3.28M | 88 | 0.13% | Reduced |
|
| 22 |
Viking Global Investors
Stamford,
Connecticut
| $830M | -$126M | 1 | 2.16% | Reduced |
|
| 23 |
Avoro Capital Advisors
New York
| $821M | +$20.5M | 3 | 10.61% | Increased |
|
| 24 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $817M | -$7.71M | 3 | 0.97% | Reduced |
|
| 25 |
Northern Trust
Chicago,
Illinois
| $768M | +$21.2M | 70 | 0.1% | Increased |
|